Vijaya Diagnostic Centre Ltd (VIJAYA)
₹1,497.50
Mkt cap
₹15,380 Cr
P/E ratio
82.00
P/B
16.10
Div yield
0.13%
ROE
18.30%
ROCE
20.50%
EPS (TTM)
₹18.26
Book value
₹93
52W range
861–1,518
Sector
Healthcare
Price history
Previous close
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services. The company provides its services across 13 cities through its 81 diagnostic centers and 11 reference laboratories. [1]
NSE VIJAYABSE 543350
Health check
Constructive
ValuationExpensive
ProfitabilityStrong
GrowthModerate
TechnicalsBullish
52-week range
−1.38% from high₹1,498
₹861+73.84% from low₹1,518
Current
₹1,497.50
Prev close
₹1,493.20
Day
+0.29%
Price performance
1D
+0.25%
1W
−1.41%
1M
+10.80%
3M
+15.49%
6M
+58.97%
1Y
+43.45%
YTD
+41.38%
Financials
Revenue, profit & margin
P/E ratio
82.0×
VIJAYA is 93% above the sector median of 42.5×
VIJAYA82.0×
Sector median42.5×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 121 | 139 | 133 | 155 | 156 | 183 | 169 | 173 | 188 | 202 | 205 | 219 | 231 | |
| Expenses | 73 | 82 | 80 | 92 | 95 | 107 | 102 | 104 | 115 | 120 | 119 | 124 | 132 | |
| Operating Profit | 48 | 57 | 52 | 63 | 61 | 76 | 67 | 69 | 74 | 82 | 86 | 96 | 99 | |
| OPM % | 40% | 41% | 39% | 41% | 39% | 42% | 40% | 40% | 39% | 41% | 42% | 44% | 43% | |
| Other Income | 6 | 7 | 3 | 3 | 4 | 5 | 5 | 5 | 7 | 6 | 5 | 2 | 9 | |
| Interest | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 8 | 9 | 9 | 11 | |
| Depreciation | 12 | 14 | 15 | 16 | 17 | 17 | 18 | 19 | 21 | 22 | 24 | 24 | 25 | |
| Profit before tax | 35 | 45 | 35 | 44 | 42 | 57 | 47 | 47 | 52 | 58 | 58 | 64 | 71 | |
| Tax % | 26% | 25% | 25% | 23% | 25% | 26% | 24% | 26% | 26% | 25% | 26% | 25% | 25% | |
| Net Profit | 26 | 34 | 26 | 34 | 32 | 42 | 35 | 35 | 39 | 43 | 43 | 48 | 53 | |
| EPS in Rs | 2.57 | 3.26 | 2.53 | 3.27 | 3.06 | 4.10 | 3.43 | 3.40 | 3.76 | 4.21 | 4.20 | 4.66 | 5.16 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move +1.25% · closed higher next day 10 of last 18
| Q2FY24 | Q3FY24 | Q4FY24 | Q1FY25 | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27† | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Broadcast | 8 Nov '23 | 5 Feb '24◦ | 8 May '24◦ | 5 Aug '24 | 7 Nov '24◦ | 12 Feb '25◦ | 12 May '25◦ | 28 Jul '25 | 4 Nov '25 | 13 Feb '26 | 7 May '26◦ | 6 Aug '26◦ |
| Earnings day | +2.74% | +1.60% | +7.77% | +1.08% | +9.19% | −7.08% | −1.97% | +6.62% | +0.54% | −0.65% | +5.86% | −1.37% |
| +1 day | +4.05% | +7.89% | +18.49% | +2.93% | +4.52% | −10.20% | −5.91% | +4.60% | −0.16% | +1.44% | +11.13% | +1.66% |
| +5 days | +6.72% | +1.85% | +15.83% | +4.91% | −1.58% | −9.88% | −6.72% | +1.49% | +0.41% | +1.44% | +10.02% | +7.61% |
| +15 days | +10.61% | +7.25% | +19.59% | +15.49% | +12.86% | +2.66% | −2.70% | −1.49% | −1.28% | −4.81% | +2.72% | +6.04% |
| +30 days | +12.85% | +0.97% | +14.05% | +15.78% | +2.14% | −5.17% | −5.00% | −1.77% | −4.07% | −11.06% | +9.70% | — |
| Filing | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Jun 202652.51%Promoter
Promoters52.51%
FIIs11.65%1.73
DIIs31.61%1.68
Public4.22%0.05
Ownership trend
Peers
7 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| LALPATHLAB | ₹1,877.50 | 56.05 | 31,514 | 0.75% | 171 | +28.02% | 798 | +19.10% | 28.00% |
| VIJAYA | ₹1,493.20 | 82.03 | 15,380 | 0.13% | 53 | +37.60% | 231 | +22.83% | 20.53% |
| METROPOLIS | ₹588.70 | 58.65 | 12,209 | 0.34% | 57 | +25.77% | 450 | +16.62% | 17.81% |
| THYROCARE | ₹576.15 | 50.74 | 9,170 | 1.62% | 51 | +34.06% | 240 | +24.34% | 35.38% |
| NEPHROPLUS | ₹697.05 | 82.36 | 7,009 | 0.00% | 32 | +34.89% | 282 | +23.69% | 15.34% |
| KRSNAA | ₹560.00 | 18.36 | 1,817 | 0.36% | 16 | −19.12% | 211 | +19.95% | 12.70% |
| SURAKSHA | ₹332.45 | 48.36 | 1,731 | 0.15% | 13 | +38.40% | 88 | +20.75% | 17.29% |
| Median: 15 Co. | ₹542.40 | 42.48 | 1,253 | 0.00% | 14 | +28.77% | 157 | +19.52% | 23.07% |
Filings
Annual reports6
Concall transcripts46
TranscriptAug 2026PPTAug 2026RECAug 2026TranscriptMay 2026PPTMay 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptAug 2025PPTAug 2025TranscriptMay 2025PPTMay 2025TranscriptFeb 2025PPTFeb 2025TranscriptNov 2024PPTNov 2024TranscriptAug 2024PPTAug 2024PPTJun 2024TranscriptMay 2024PPTMay 2024
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 2 Sep - Analyst/institutional investor meeting scheduled for 10 September 2026 at 11:00 a.m., hosted by Emkay Global.Announcement under Regulation 30 (LODR)-Change in Management 2 Sep - Dr. Venkata Naresh Yallapragada appointed Chief Information Officer effective September 2, 2026.Announcement under Regulation 30 (LODR)-Newspaper Publication 27 Aug - Intimation of 24th AGM - Post Dispatch Newspaper AdvertisementAnnouncement under Regulation 30 (LODR)-Change in Management 26 Aug - Ms. Naga Vasudha Tadepalli resigned as Company Secretary and Compliance Officer, effective close of business August 26, 2026.Weblink Letter To Shareholders - As Per Regulation 36(1)(B) Of
SEBI (LODR) Regulations, 2015 26 Aug - Web-link letters sent for FY2025-26 annual report; 24th AGM on September 24, 2026.